Skip to main content
letter
. 2017 Mar 14;18:123. doi: 10.1186/s13063-017-1843-5

Table 3.

Frequency of subjects and number of recurrences in the two hospital groups

Treatment received Hospital groupa Total N N of events (# of recurrences) Recurrences in [%]
KLH Group 1 95 70 74
Group 2 172 93 54
Overall 267 163 61
Mitomycin C Group 1 90 23 26
Group 2 166 64 39
Overall 256 87 34

aGroup 1 = 6 hospitals, Group 2 = 12 hospitals

KLH Keyhole Limpet Hemocyanin